06/02/2026
In the last 2 weeks I had the opportunity to attend three events that allow me to share the patient journey, inspire the research and drug development community, and align with my missions of championing the patient experience and perspective to create better healthcare outcomes in both clinical care and in clinical research.
First up, I spoke on a panel at the annual meeting about my CF diagnosis journey and the need for prenatal and carrier screenings to support early treatment and care for patients and families diagnosed with genetic diseases. It’s a pleasure to work with such a motivated group of individuals who understand this need and work to develop technologies and spread education to providers on genetic testing.
Next, I gave the patient keynote at the IDSA and the American Society for Microbiology Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) Conference in Vegas, sharing about my health experiences dealing with antimicrobial resistant infections and the needs for the development of novel therapeutics and patient collaboration with both industry and healthcare professionals to humanize the patient experience and spur innovation and improve health outcomes.
Lastly, I attended where I had the pleasure of connecting with colleagues old and new and having meaningful discussions on opportunities to leverage patient insights to improve products and trials to optimize patient experiences. I was one of a few patient representatives at this meeting.
The central theme of empowering patients in being collaborators and partners in developing better experiences and outcomes resonated in all conversations.
Ready for the opportunities this spring will bring!